Why the study?
Does propofol, thiopentone, or midazolam provide better induction, recovery, and safety profiles for patients undergoing cardioversion?
Does propofol, thiopentone, or midazolam provide better induction, recovery, and safety profiles for patients undergoing cardioversion?
Thiopentone appears to be the most satisfactory anaesthetic agent for cardioversion compared to propofol and midazolam due to a more favorable recovery and side effect profile.
May favor thiopentone or propofol over midazolam for cardioversion recovery; hypothesis-generating and should not yet change practice.
This study compares the induction and recovery characteristics, haemodynamic changes and side effects of propofol, thiopentone and midazolam when used as the anaesthetic agents for cardioversion. Recovery after midazolam was significantly longer (p less than 0.05) than with either thiopentone or propofol. There was no difference in the recovery times between thiopentone and propofol. There was a significant decrease in mean arterial pressure 2 minutes after induction with propofol and midazolam. Three patients each in the thiopentone and propofol groups needed assisted ventilation because of apneoea, and four patients each in the propofol and midazolam groups had low Spo2 values (less than 95%). Flumazenil was used to reverse the effects of midazolam in eight patients and five of these were still drowsy 4 hours after the procedure. This study indicates that thiopentone is the most satisfactory agent for anaesthesia for cardioversion.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: